Active	Status	Sponsor type	Region	Phase	Filter
22 Active 5 Inactive 27 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Huang, David
NCT02864953 / 2017-004854-41: Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction	Terminated	3	535	Europe, Canada, Japan, US, RoW	BIIB093, glibenclamide, glibenclamide intravenous (IV), glyburide, CIRARA, Placebo	Remedy Pharmaceuticals, Inc.	Brain Edema, Stroke, Acute	08/23	08/23
REPAVID-22, NCT05254990 / 2021-006951-32: Reparixin add-on Therapy to Std Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia	Terminated	3	409	Europe, US, RoW	Reparixin, Repertaxin L-lysine salt, Placebo, Matched placebo	Dompé Farmaceutici S.p.A	Infectious Pneumonia, Severe COVID-19	09/24	09/24
NCT04190186: Hybrid Ablation Plus Medical Therapy for Persistent Atrial Fibrillation	Completed	N/A	55	US	Insertable Cardiac Monitor, BioMonitor3® or future generation of Biotronik ICM	University of Rochester, Biotronik, Inc.	Persistent Atrial Fibrillation	02/24	02/24
VA IR vs IO, NCT05250986: Comparison of Visual Acuity Performed in Office Versus In Residence	Recruiting	N/A	325	US, RoW	GoCheck Kids (iOS), GoCheck Kids (Windows), GoCheck at Home (iOS), GoCheck at Home (Windows)	Gobiquity Mobile Health	Refractive Errors	05/22	09/22
Pinto-Coelho, Laura
No trials found